Related Experiment Video
Updated: Mar 11, 2026

Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
Sprouty4 mRNA variants and protein expressions in breast and lung-derived cells
Angelina Doriguzzi1, Jihen Salhi1, Hedwig Sutterlüty-Fall1
1Institute of Cancer Research, Comprehensive Cancer Center, Department of Medicine I, Medical University of Vienna, A-1090 Vienna, Austria.
Abstract:
Sprouty proteins are modulators of mitogen-induced signalling processes and are therefore hypothesized to affect malignant diseases. As a member of the Sprouty family, Sprouty4 has been previously shown to function as a tumour suppressor in lung and breast cancer. The present study analysed the expression of two known Sprouty4 splice variants in cells established from malignant and normal lung and breast tissues using semi-quantitative reverse transcription-polymerase chain reaction and immunoblotting. The results indicated that the expression of the two messenger RNA (mRNA) variants was reduced in the cells derived from malignant tissue in comparison to the normal counterparts. Although the expression of the two splice variants were associated in both tissue types, on average, the relative expression of the longer variant was slightly increased in malignant cells compared with normal tissues. Notably, the protein levels reflected the expression observed at the mRNA level only in breast-derived cells. Contrarily, with regards to the measured mRNA levels, Sprouty4 protein was disproportional augmented in lung cells known to harbour the mutated K-Ras gene.
Insights
Sprouty4 expression, a tumor suppressor, is reduced in malignant lung and breast cells. However, Sprouty4 protein levels are disproportionately increased in lung cancer cells with mutated K-Ras.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Sprouty proteins regulate mitogen-induced signaling pathways.
- Sprouty4 acts as a tumor suppressor in lung and breast cancers.
- Alterations in Sprouty4 may contribute to malignant disease progression.
Purpose of the Study:
- To analyze the expression of two Sprouty4 splice variants in malignant and normal lung and breast tissues.
- To investigate the relationship between Sprouty4 mRNA and protein levels in cancer cells.
- To explore the differential expression of Sprouty4 in relation to K-Ras mutations.
Main Methods:
- Semi-quantitative reverse transcription-polymerase chain reaction (RT-PCR) for mRNA analysis.
- Immunoblotting for protein expression assessment.
- Comparison of expression in cell lines derived from malignant and normal tissues.
Main Results:
- Reduced expression of both Sprouty4 mRNA variants in malignant versus normal lung and breast cells.
- A slight increase in the relative expression of the longer Sprouty4 variant in malignant cells.
- Sprouty4 protein levels mirrored mRNA levels in breast cells but were disproportionately increased in lung cells with mutated K-Ras.
Conclusions:
- Sprouty4 expression is dysregulated in lung and breast cancers.
- Differential regulation of Sprouty4 at mRNA and protein levels occurs in lung cancer.
- Sprouty4's role in cancer may be context-dependent, influenced by factors like K-Ras mutation status.
More Related Videos
09:58Using RNA-sequencing to Detect Novel Splice Variants Related to Drug Resistance in In Vitro Cancer Models
Published on: December 9, 2016
10:57Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay
Published on: August 14, 2018
Related Concept Videos
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
What is Gene Expression?
Regulation of Expression at Multiple Steps
Leaky Scanning